Denali Medical II, Inc.

PLYMOUTH, MN · Founded 2010 · CIK 0001489642 · Biotech · Defunct

Biotherapeutics and medicines for serious diseases, including brain-targeted therapies

denalitherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$4.0M
1 Form D · Apr 2010
198 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2148VIRONGY, LLC——
2149EpiBiologics, Inc.—$30M
2150Egalet Corp—$42M
2151Denali Medical II, Inc.—$4.0M
2152KANNALIFE SCIENCES, INC.—$1.5M
2153QRKANSWER LLC——
2154Valeo Pharma Inc.—$787K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Ali BehbahaniDirector
  • Michael DeManeDirector
  • Albert GrafDirector
  • Thomas HektnerDirector · Executive Officer
  • D. KaufmanExecutive Officer
  • John NehraDirector
  • James NessExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.